Rapid antibody response to influenza vaccination in 'at risk' groups

R. Lambkin, J. S. Oxford, L. Biao, A. Al-Jabri, D. Fleming

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Persons attending for routine influenza vaccination in an urban practice each provided three specimens of blood for evaluating their immunological response. 138 (67%) of the 206 persons were defined as 'at risk' by reason of morbidity as given in the guidelines published by the Chief Medical Officer. The mean age was 67 yr and 65% were aged 65 yr or more. By day 7, 71% of 31 persons had protective H1N1 titres, 61% H3N2 and 42% B. These proportions were similar to those found at day 14 and at day 21 based on 159 persons. These findings suggest that an effective immune response is mounted within seven days of vaccination indicating that the vaccination of persons 'at risk' is worthwhile even after an epidemic has established itself. This is not a reason to modify present policy of routine vaccination in early winter well before epidemics are likely to occur. (C) 2000 Elsevier Science Ltd.

Original languageEnglish
Pages (from-to)2307-2311
Number of pages5
JournalVaccine
Volume18
Issue number21
DOIs
Publication statusPublished - Apr 2000

Fingerprint

risk groups
influenza
Human Influenza
Antibody Formation
Vaccination
vaccination
antibodies
immune response
morbidity
Guidelines
Morbidity
winter
blood

Keywords

  • Antibody
  • Influenza
  • Vaccination

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Rapid antibody response to influenza vaccination in 'at risk' groups. / Lambkin, R.; Oxford, J. S.; Biao, L.; Al-Jabri, A.; Fleming, D.

In: Vaccine, Vol. 18, No. 21, 04.2000, p. 2307-2311.

Research output: Contribution to journalArticle

Lambkin, R, Oxford, JS, Biao, L, Al-Jabri, A & Fleming, D 2000, 'Rapid antibody response to influenza vaccination in 'at risk' groups', Vaccine, vol. 18, no. 21, pp. 2307-2311. https://doi.org/10.1016/S0264-410X(99)00437-5
Lambkin, R. ; Oxford, J. S. ; Biao, L. ; Al-Jabri, A. ; Fleming, D. / Rapid antibody response to influenza vaccination in 'at risk' groups. In: Vaccine. 2000 ; Vol. 18, No. 21. pp. 2307-2311.
@article{0bafe19891384c4c8ccc4c688b4f73b9,
title = "Rapid antibody response to influenza vaccination in 'at risk' groups",
abstract = "Persons attending for routine influenza vaccination in an urban practice each provided three specimens of blood for evaluating their immunological response. 138 (67{\%}) of the 206 persons were defined as 'at risk' by reason of morbidity as given in the guidelines published by the Chief Medical Officer. The mean age was 67 yr and 65{\%} were aged 65 yr or more. By day 7, 71{\%} of 31 persons had protective H1N1 titres, 61{\%} H3N2 and 42{\%} B. These proportions were similar to those found at day 14 and at day 21 based on 159 persons. These findings suggest that an effective immune response is mounted within seven days of vaccination indicating that the vaccination of persons 'at risk' is worthwhile even after an epidemic has established itself. This is not a reason to modify present policy of routine vaccination in early winter well before epidemics are likely to occur. (C) 2000 Elsevier Science Ltd.",
keywords = "Antibody, Influenza, Vaccination",
author = "R. Lambkin and Oxford, {J. S.} and L. Biao and A. Al-Jabri and D. Fleming",
year = "2000",
month = "4",
doi = "10.1016/S0264-410X(99)00437-5",
language = "English",
volume = "18",
pages = "2307--2311",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "21",

}

TY - JOUR

T1 - Rapid antibody response to influenza vaccination in 'at risk' groups

AU - Lambkin, R.

AU - Oxford, J. S.

AU - Biao, L.

AU - Al-Jabri, A.

AU - Fleming, D.

PY - 2000/4

Y1 - 2000/4

N2 - Persons attending for routine influenza vaccination in an urban practice each provided three specimens of blood for evaluating their immunological response. 138 (67%) of the 206 persons were defined as 'at risk' by reason of morbidity as given in the guidelines published by the Chief Medical Officer. The mean age was 67 yr and 65% were aged 65 yr or more. By day 7, 71% of 31 persons had protective H1N1 titres, 61% H3N2 and 42% B. These proportions were similar to those found at day 14 and at day 21 based on 159 persons. These findings suggest that an effective immune response is mounted within seven days of vaccination indicating that the vaccination of persons 'at risk' is worthwhile even after an epidemic has established itself. This is not a reason to modify present policy of routine vaccination in early winter well before epidemics are likely to occur. (C) 2000 Elsevier Science Ltd.

AB - Persons attending for routine influenza vaccination in an urban practice each provided three specimens of blood for evaluating their immunological response. 138 (67%) of the 206 persons were defined as 'at risk' by reason of morbidity as given in the guidelines published by the Chief Medical Officer. The mean age was 67 yr and 65% were aged 65 yr or more. By day 7, 71% of 31 persons had protective H1N1 titres, 61% H3N2 and 42% B. These proportions were similar to those found at day 14 and at day 21 based on 159 persons. These findings suggest that an effective immune response is mounted within seven days of vaccination indicating that the vaccination of persons 'at risk' is worthwhile even after an epidemic has established itself. This is not a reason to modify present policy of routine vaccination in early winter well before epidemics are likely to occur. (C) 2000 Elsevier Science Ltd.

KW - Antibody

KW - Influenza

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=0034093703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034093703&partnerID=8YFLogxK

U2 - 10.1016/S0264-410X(99)00437-5

DO - 10.1016/S0264-410X(99)00437-5

M3 - Article

VL - 18

SP - 2307

EP - 2311

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 21

ER -